Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP308887.RAk-n9UHHY4ORKDXu5Ws_Z7DKd8xPnph0Zg8kRiZtDTA8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP308887.RAk-n9UHHY4ORKDXu5Ws_Z7DKd8xPnph0Zg8kRiZtDTA8130_assertion type Assertion NP308887.RAk-n9UHHY4ORKDXu5Ws_Z7DKd8xPnph0Zg8kRiZtDTA8130_head.
- NP308887.RAk-n9UHHY4ORKDXu5Ws_Z7DKd8xPnph0Zg8kRiZtDTA8130_assertion description "[The average IMD in intermediate and high-grade malignant MFS (4.03 and 4.09, respectively) was significantly higher than in low-grade malignant MFS (2.73).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP308887.RAk-n9UHHY4ORKDXu5Ws_Z7DKd8xPnph0Zg8kRiZtDTA8130_provenance.
- NP308887.RAk-n9UHHY4ORKDXu5Ws_Z7DKd8xPnph0Zg8kRiZtDTA8130_assertion evidence source_evidence_literature NP308887.RAk-n9UHHY4ORKDXu5Ws_Z7DKd8xPnph0Zg8kRiZtDTA8130_provenance.
- NP308887.RAk-n9UHHY4ORKDXu5Ws_Z7DKd8xPnph0Zg8kRiZtDTA8130_assertion SIO_000772 11213831 NP308887.RAk-n9UHHY4ORKDXu5Ws_Z7DKd8xPnph0Zg8kRiZtDTA8130_provenance.
- NP308887.RAk-n9UHHY4ORKDXu5Ws_Z7DKd8xPnph0Zg8kRiZtDTA8130_assertion wasDerivedFrom befree-2016 NP308887.RAk-n9UHHY4ORKDXu5Ws_Z7DKd8xPnph0Zg8kRiZtDTA8130_provenance.
- NP308887.RAk-n9UHHY4ORKDXu5Ws_Z7DKd8xPnph0Zg8kRiZtDTA8130_assertion wasGeneratedBy ECO_0000203 NP308887.RAk-n9UHHY4ORKDXu5Ws_Z7DKd8xPnph0Zg8kRiZtDTA8130_provenance.